Related Experiment Video
Updated: May 5, 2026

09:16
A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
17.6K
[Neuromodulation as an intervention for addiction: overview and future prospects]
Tijdschrift Voor Psychiatrie
|November 19, 2013
Summary
Neuromodulation techniques like EEG neurofeedback and TMS show promise for treating addiction by reducing drug use and cravings. Further research is needed to confirm the safety and effectiveness of these advanced therapies.
Area of Science:
- Neuroscience
- Addiction Medicine
- Neuromodulation
Context:
- Addiction is a significant public health concern with evolving treatment strategies.
- Neuromodulation techniques offer novel, targeted interventions for addiction.
- This review focuses on electroencephalography (EEG) neurofeedback, real-time functional magnetic resonance imaging (rt-fMRI) neurofeedback, transcranial magnetic stimulation/transcranial direct current stimulation (TMS/tDCS), and deep brain stimulation (DBS).
Purpose:
- To review and discuss studies investigating the efficacy of neuromodulation techniques in treating addiction.
- To explore the potential of EEG neurofeedback, rt-fMRI neurofeedback, TMS/tDCS, and DBS for addiction intervention.
- To highlight findings from Dutch studies in the field of neuromodulation for addiction.
Summary:
- EEG neurofeedback demonstrated positive effects on drug use, treatment compliance, and cue reactivity in cocaine and alcohol dependence.
- rt-fMRI neurofeedback showed potential in reducing nicotine craving by modulating the anterior cingulate cortex in smokers.
- TMS/tDCS and DBS targeting areas like the anterior cingulate cortex, dorsolateral prefrontal cortex, and nucleus accumbens showed promise in reducing craving and treating alcohol and heroin dependence.
Impact:
- Neuromodulation allows for the direct application of neuroscientific principles to addiction treatment.
- These techniques offer a promising avenue for developing more effective and personalized addiction therapies.
- Continued research is crucial to establish the efficacy, safety, and feasibility of neuromodulation for widespread clinical use.
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
1.6K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.6K
Neurochemical Transmission: Sites of Drug Action
3.5K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.5K
Drug Dependence
1.9K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.9K
Drugs Acting on Autonomic Ganglia: Stimulants
2.2K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.2K

